Cancer risks of anti-hyperglycemic drugs for type 2 diabetes treatment – a clinical appraisal
A clinical appraisal of existing scientific literature sought to assess the need for long-term prospective epidemiological studies to investigate an increased cancer risk of anti-hyperglycemic medication in type 2 diabetes.
Source: Journal of Diabetes and Its Complications - Category: Endocrinology Authors: Jiten Vora, Kausik Ray, Mikhail Kosiborod, Neil R. Poulter, Sanjay Rajagopalan, Lawrence A. Leiter Source Type: research
More News: Cancer | Cancer & Oncology | Diabetes | Diabetes Type 2 | Endocrinology | Epidemiology | Legislation | Study